Seven years of HAART impact on ophthalmic management of HIV-infected patients

Ocular Immunology and Inflammation

Volumn 13, Issue 2-3, 2005, Pages 213-218

  Kahraman, Günal ^a   Krepler, Katharina ^a   Franz, Carmen ^a   Ries, Eva ^a   Maar, Noemi ^a   Wedrich, Andreas ^a   Rieger, Armin ^b   Dejaco Ruhswurm, Irene ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b Universitatsklinik fur Dermatologie   (Austria)

Author keywords

Acquired immunodeficiency syndrome (AIDS); Cytomegalovirus (CMV) retinitis; Highly active antiretroviral therapy (HAART); HIV infection

Indexed keywords

ANTIRETROVIRUS AGENT; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; VIRUS RNA;

ADOLESCENT; ADULT; AGED; AIDS RELATED COMPLEX; ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS; DRY EYE; FEMALE; FOLLOW UP; HEALTH STATUS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; IMMUNE RESPONSE; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MICROANGIOPATHY; MORBIDITY; RETINITIS; SURVIVAL; TREATMENT OUTCOME; UVEITIS; AUSTRIA; CD4 LYMPHOCYTE COUNT; COMPARATIVE STUDY; GENETICS; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOLOGY; MIDDLE AGED; RETROSPECTIVE STUDY;

ADOLESCENT; ADULT; AGED; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; AUSTRIA; CD4 LYMPHOCYTE COUNT; CYTOMEGALOVIRUS RETINITIS; FEMALE; FOLLOW-UP STUDIES; HIV-1; HUMANS; INCIDENCE; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RNA, VIRAL; TREATMENT OUTCOME;

EID: 25144470858     PISSN: 09273948     EISSN: 17445078     Source Type: Journal    
DOI: 10.1080/09273940490912443     Document Type: Article

References (31)

1. Carpenter CC, Fischl MA, Hammer SM, Hirsch MS, Jacobson DM, Katzenstein DA, Montaner JSG, Richman DD, Saag MS, Schooley RT, Thompson MA, Vella S, Yeni PG, Volberding PA. Antiretroviral therapy for HIV infection in 1997. Updated recommendations of the international AIDS Society - USA panel. J Am Med Assoc. 1997;277:1962-1969.
2. Deeks SG, Smith M, Holodniy M, Kahn JO. HIV-1 protease inhibitors: a review for clinicians. J Am Med Assoc. 1997;277:145-153.
3. Gulick RM, Mellors JW, Havlir D, Eron, JJ, Gonzalez C, McMahon D, Richman DD, Valentine FT, Jonas LJ, Meibohm A, Emini EA, Chodakewitz JA. Treatment with indinavir, zidovudine and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy. N Engl J Med. 1997;337:734-739.
4. Hogg RS, Heath KV, Yip B, Craib KJ, O'Shaughnessy MV, Schechter MT, Montaner JS. Improved survival among HIV-infected individuals following initiation of antiretroviral therapy. J Am Med Assoc. 1997;279:450-454.
5. Mouton Y, Alfandari S, Valette M, Cartier F, Dellamonica P, Humbert G, Lang JM, Massip P, Mechali D, Leclercq P, Modai J, Portier H. Impact of protease inhibitors on AIDS-defining events and hospitalizations in 10 French AIDS reference centres. AIDS. 1997;11:F101-F105.
6. Furtado MR, Callaway DS, Phair JP, Kunstman KJ, Stanton JL, Macken CA, Perelson AS, Wolinsky SM. Persistence of HIV-1 transcription in peripheral-blood mononuclear cells in patients receiving potent antiretroviral therapy. N Engl J Med. 1999;340(21):1614-1622.
7. Natarajan V, Bosche M, Metcalf JA, Ward DJ, Lane HC, Kovacs JA. HIV-1 replication in patients with undetectable plasma virus receiving HAART. Highly active antiretroviral therapy. Lancet. 1999;353(9147):119-120.
8. Geier SA, Libera S, Klauss V, Goebel FD. Sicca syndrome in patients infected with the human immunodeficiency virus. Ophthalmology. 1995;102(9):1319-1324.
9. Rutherford GW, Payne SF, Lemp GF. The epidemiology of AIDS-related Kaposi's sarcoma in San Francisco. J Acquir Immune Defic Syndr. 1990;3(Suppl 1):S4-7.
10. Haverkos HW, Friedmann-Kien AE, Drotman DP, Morgan WM. The changing incidence of Kaposi's sarcoma among patients with AIDS. J Am Acad Dermatol. 1990;22(6 Pt 2);1250-1253.
11. Ghabial R, Quivey JM, Dunn Jr JP, Char DH. Radiation therapy of acquired immunodeficiency syndrome-related Kaposi's sarcoma of the eyelids and conjunctiva. Arch Ophthalmol. 1992;110(10):1423-1426.
12. Jones JL, Hanson DL, Dworkin MS, Jaffe HW. Incidence and trends in Kaposi's sarcoma in the era of effective antiretroviral therapy. J Acquir Immune Defic Syndr. 2000;24(3):270-274.
13. Ragozzino MW, Melton LJ, Kurland LT, Chu CP, Perry HO. Population-based study of herpes zoster and its sequelae. Medicine. 1982;61(5):310-316.
14. Veenstra J, Krol A, van Praag RM, Frissen PH, Schellekens PT, Lange JM, Coutinho RA, van der Meer JT. Herpes zoster, immunological deterioration and disease progression in HIV-1 infection. AIDS. 1995;9(10):1153-1158.
15. Glesby MJ, Moore RD, Chaisson RE. Clinical spectrum of herpes zoster in adults infected with human immunodeficiency virus. Clin Infect Dis. 1995;21(2):370-375.
16. Jabs DA, Green WR, Fox R, Polk BF, Bartlett JG. Ocular manifestations of the acquired immunodeficiency syndrome. Ophthalmology. 1989;96:1092-1099.
17. Jacobson MA. Current management of cytomegalovirus disease in patients with AIDS. AIDS Res Hum Retrovir. 1994;10:917-923.
18. Ries E, Muhlbauer B, Ruhswurm I, Krepier K, Derbolav A, Svolba G, Rieger A, Wedrich A. Evaluation of cytomegalovirus retinitis management. Outcome of four years of cytomegalovirus therapy. Ophthalmologica. 1998;212(4):239-243.
19. Kuppermann BD, Petty JG, Richmann DD, Mathews WC, Fullerton SC, Rickman LS, Freeman WR. Correlation between CD4+ counts and prevalence of cytomegalovirus retinitis and human immun-odeficiency virus-related noninfectious retinal vasculopathy in patients with acquired immune deficiency syndrome. Am J Ophthalmol. 1993;115:575-582.
20. Holland GN, Sidikaro Y, Kreiger AE, Hardy D, Sakamoto MJ, Frenkel LM, Winston DJ, Gottlieb MS, Bryson YJ, Champlin RE, Ho WG, Winters RE, Wolfe PR, Cherry JD. Treatment of cytomegalovirus retinitis with ganciclovir. Ophthalmology. 1987;94:815-823.
21. Jacobson MA, O'Donell JJ, Mills J. Foscarnet treatment of cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome. Antimicrob Agents Chemother. 1989;33:736-741.
22. Studies of Ocular Complications of AIDS Research Group in Collaboration with the AIDS Clinical Trials Group. Parenteral cidofovir for cytomegalovirus retinitis in patients with AIDS: the HPMPC peripheral cytomegalovirus retinitis trial. Ann Intern Med. 1997;126:264-274.
23. Reed JB, Schwab IR, Gordon J, Morse LS. Regression of cytomegalovirus retinitis associated with protease-inhibitor treatment in patients with AIDS. Am J Ophthalmol. 1997;124:199-205.
24. Ruhswurm I, Ries E, Krepler K, Derbolav A, Rieger A, Armbruster C, Wedrich A. Control of cytomegalovirus retinitis after combination antiretroviral therapy. Acta Ophthalmol Scand. 1999;77(4):471-473.
25. Vrabec T, Baldassano VF, Whitcup SM. Discontinuation of maintenance therapy in patients with quiescent cytomegalovirus retinitis and elevated CD4+ counts. Ophthalmology. 1998;105:1259-1264.
26. Tural C, Romeu J, Sirera G, Andreu D, Conejero M, Ruiz S, Jou A, Bonjoch A, Ruiz L, Arnó A, Clotet B. Long-lasting remission of cytomegalovirus retinitis without maintenance therapy in human immunodeficiency virus-infected patients. J Infect Dis. 1998;177:1080-1083.
27. Jacobson MA, Zegans M, Pavan PR, et al. Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy. Lancet. 1997;349:1443-1445.
28. Freeman WR, Chen A, Henderly DE, et al. Prevalence and significance of acquired immunodeficiency syndrome-related retinal microvasculopathy. Am J Ophthalmol. 1989;107:229-235.
29. Holland GN, Repose JS, Pettit TH, Gottlieb MS, Yee RD, Foos RY. Acquired immunodeficiency syndrome: ocular manifestations. Ophthalmology. 1983;90:859-873.
30. Glasgow BJ, Weisberger AK. A quantitative and cartographic study of retinal microvasculopathy in acquired immunodeficiency syndrome. Am J Ophthalmol. 1994;118:46-56.
31. Doan S, Cochereau I, Guvenisik N, Diraison MC, Mousalatti H, Thanh HX. Cytomegalovirus retinitis in HIV-infected patients with and without highly active antiretroviral therapy. Am J Ophthalmol. 1999;128(2):250-251.